Design, synthesis, and biological evaluation of a potent, PKC selective, B-ring analog of bryostatin

被引：31

作者：

Wender, PA ^{[1
]}

Verma, VA

机构：

[1] Stanford Univ, Dept Chem, Stanford, CA 94305 USA

[2] Stanford Univ, Dept Mol Pharmacol, Stanford, CA 94305 USA

来源：

ORGANIC LETTERS | 2006年 / 8卷 / 09期

关键词：

D O I：

10.1021/ol060457z

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

The first member of a new class of five-membered B-ring analogs of bryostatin has been synthesized and tested for its ability to bind and translocate protein kinase C (PKC). This synthesis extends the utility of our previously introduced macrotransacetalization strategy to the formation of five-membered dioxolane B-ring analogs. This analog exhibits potent, single-digit nanomolar affinity to PKC and selectively translocates novel PKC isozymes.

引用

页码：1893 / 1896

页数：4

共 41 条

[1] Protein synthesis required for long-term memory is induced by PKC activation on days before associative learning
Alkon, DL
Epstein, H
Kuzirian, A
Bennett, MC
Nelson, TJ
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (45) : 16432 - 16437
[2] Simplified analogs of bryostatin with anticancer activity display greater potency for translocation of PKCδ-GFP
Baryza, JL
Brenner, SE
Craske, ML
Meyer, T
Wender, PA
[J]. CHEMISTRY & BIOLOGY, 2004, 11 (09): : 1261 - 1267
[3] Regulation of cell apoptosis by protein kinase c δ
Brodie, C
Blumberg, PM
[J]. APOPTOSIS, 2003, 8 (01) : 19 - 27
[4] Protein kinase C: A worthwhile target for anticancer drugs?
Caponigro, F
French, RC
Kaye, SB
[J]. ANTI-CANCER DRUGS, 1997, 8 (01) : 26 - 33
[5] IMPROVED ENANTIOSELECTIVITY IN ASYMMETRIC DIHYDROXYLATIONS OF TERMINAL OLEFINS USING PYRIMIDINE LIGANDS
CRISPINO, GA
JEONG, KS
KOLB, HC
WANG, ZM
XU, DQ
SHARPLESS, KB
[J]. JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (15) : 3785 - 3786
[6] Targeting protein kinase C: New therapeutic opportunities against high-grade malignant gliomas?
da Rocha, AB
Mans, DRA
Regner, A
Schwartsmann, G
[J]. ONCOLOGIST, 2002, 7 (01) : 17 - 33
[7] Modulation of resistance to ara-C by bryostatin in fresh blast cells from patients with AML
Elgie, AW
Sargent, JM
Alton, P
Peters, GJ
Noordhuis, P
Williamson, CJ
Taylor, CG
[J]. LEUKEMIA RESEARCH, 1998, 22 (04) : 373 - 378
[8] Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice
Etcheberrigaray, R
Tan, M
Dewachter, I
Kuipéri, C
Van der Auwera, I
Wera, S
Qiao, LX
Bank, B
Nelson, TJ
Kozikowski, AP
Van Leuven, F
Alkon, DL
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (30) : 11141 - 11146
[9] Total synthesis of bryostatin 2
Evans, DA
Carter, PH
Carreira, EM
Charette, AB
Prunet, JA
Lautens, M
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1999, 121 (33) : 7540 - 7552
[10] Protein kinase C and prostate carcinogenesis: Targeting the cell cycle and apoptotic mechanisms
Gavrielides, MV
Frijhoff, AF
Conti, CJ
Kazanietz, MG
[J]. CURRENT DRUG TARGETS, 2004, 5 (05) : 431 - 443

← 1 2 3 4 5 →